AXR-2102

N/A

Report date: 2023/07/25 11:02:52
NME

Base Information

Drug NameAXR-2102
Drug Alias NameAXR-2102
ClassificationSmall molecules
Mechanisms of ActionSpleen tyrosine kinase inhibitors
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAxceso Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAxceso Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A